Health Impacts of Interferon-beta Use in MS MStranslate May 16, 2017 Interferon-beta, Research, Treatments Research Summary: Evaluating the safety of β-interferons in MS Research from the University of British Columbia has looked at the long-term health...
Secondary Progressive Multiple Sclerosis & Statins MStranslate May 15, 2017 Research, Treatments There has been a lot of media attention recently on a trial testing statins as a treatment for multiple sclerosis (MS). The study is being led by...
Multiple Sclerosis Clinical Trial Update: Laquinimod MStranslate May 9, 2017 Clinical Trials, Laquinimod, Research What is laquinimod? Laquinimod is a once-daily oral medication that has been developed and tested for the treatment of relapsing-remitting multiple...
BMI & Lipid Levels Impact MS Progression MStranslate April 26, 2017 Diet, Lifestyle, Research 2 Comments Research Summary: An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating...
Mitochondrial Dysfunction & ER Stress in MS MStranslate April 4, 2017 Research, Treatments Research Summary: Rab32 connects ER stress to mitochondrial defects in multiple sclerosis Mitochondria are often referred to as the...
Regulatory T Cells Promote Remyelination MStranslate March 26, 2017 Remyelination, Research Research Summary: Regulatory T cells promote myelin regeneration in the central nervous system When we think about treating multiple sclerosis,...
Can Blood Test Determine Type of Multiple Sclerosis? MStranslate February 8, 2017 Basic Sciences, Research Research Summary: Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression A recent Australian...
HALT-MS: Five Year Study Results MStranslate February 2, 2017 Research, Stem Cells, Treatments Research Summary: High dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS The 5 year results of the HALT-MS trial were...
Case Studies Reveal New Alemtuzumab Side-effects MStranslate January 26, 2017 Alemtuzumab, Research, Treatments Research Summary: Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy A recent report in Lancet Neurology has highlighted two case...
Dimethyl Fumarate Linked to Liver Injury MStranslate January 17, 2017 Dimethyl fumarate, Research, Treatments Research Summary: Liver injury associated with dimethyl fumarate in multiple sclerosis patients Last Friday, members of the Office of Surveillance...
